3.12
0.01 (0.32%)
Penutupan Terdahulu | 3.11 |
Buka | 3.13 |
Jumlah Dagangan | 28,144,131 |
Purata Dagangan (3B) | 45,046,020 |
Modal Pasaran | 36,016,345,088 |
Harga / Pendapatan (P/E Ke hadapan) | 48.78 |
Harga / Jualan (P/S) | 0.920 |
Harga / Buku (P/B) | 39.13 |
Julat 52 Minggu | |
Tarikh Pendapatan | 20 Mar 2025 |
Hasil Dividen (DY TTM) | 0.18% |
Margin Keuntungan | -0.09% |
Margin Operasi (TTM) | 0.37% |
EPS Cair (TTM) | -0.010 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 9.40% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -66.90% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 15.79% |
Nisbah Semasa (MRQ) | 1.74 |
Aliran Tunai Operasi (OCF TTM) | -63.74 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 453.70 M |
Pulangan Atas Aset (ROA TTM) | 0.71% |
Pulangan Atas Ekuiti (ROE TTM) | -0.32% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Distribution (AU) | Bercampur | Bercampur |
Medical Distribution (Global) | Menurun | Menurun | |
Stok | SIGMAHEALT FPO [SIG] | - | - |
AISkor Stockmoo
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -3.5 |
Purata | -0.38 |
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model. |
|
Sektor | Healthcare |
Industri | Medical Distribution |
Gaya Pelaburan | Large Growth |
% Dimiliki oleh Orang Dalam | 3.36% |
% Dimiliki oleh Institusi | 48.64% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |